CAS NO: | 449811-01-2 |
生物活性 | Pamapimod (Ro4402257) is a potent, selective and orally activep38 MAPKinhibitor withIC50s of 14 nM and 480 nM andKis of 1.3 nM and 120 nM forp38αandp38β, respectively. Pamapimod has no activity againstp38δorp38γisoforms. Pamapimod has the potential for rheumatoid arthritis and other autoimmune diseases treatment[1]. | ||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||
体外研究 (In Vitro) | Pamapimod binds to JNK kinases with Kivalues of 190 nM, 16 nM and 19 nM for Jnk1, Jnk2 and Jnk3, respectively[1]. | ||||||||||||||||
体内研究 (In Vivo) | Pamapimod (0-150 mg/kg; oral gavage; once daily; DBA/1J female mice) treatment reduces inflammation and bone loss in murine collagen-induced arthritis[1].
| ||||||||||||||||
分子量 | 406.38 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C19H20F2N4O4 | ||||||||||||||||
CAS 号 | 449811-01-2 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : ≥ 34 mg/mL(83.67 mM) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |